Novartis CEO says organization can 'stand proud' after hiding manipulated data from FDA

Published: 7/08/2019
Novartis CEO says organization can 'stand proud' after hiding manipulated data from FDA
Source: THEHILL.COM

Drug company Novartis is defending its decision to withhold information from the Food and Drug Administration (FDA) about partially faulty data in its application for approval of a $2.1 million drug. Novartis said it didn't tell the FDA...

Read more
Related news
Comment
FACEBOOK